Skip to main content
Top
Published in: Endocrine 2/2009

01-04-2009 | CASE STUDY

The novel compound heterozygous mutations, V434del and W666X, in WFS1 gene causing the Wolfram syndrome in a Chinese family

Authors: Jie Hong, Yu-wen Zhang, Hui-Jie Zhang, Hui-ying Jia, Yu Zhang, Xiao-yi Ding, Dan-yang Zhou, Hui-ping Chen, Xiao-hua Jiang, Bin Cui, Xiao-ying Li, Guang Ning

Published in: Endocrine | Issue 2/2009

Login to get access

Abstract

Wolfram syndrome (WFS), also known as DIDMOAD, is an infrequent cause of diabetes mellitus. WFS is an autosomal recessive neurodegenerative disease characterized by various clinical manifestations such as diabetes mellitus, optic atrophy, diabetes insipidus, deafness, neurological symptoms, renal tract abnormalities, psychiatric disorders, and gonadal disorders. The majority of patients with WFS carry the loss of function mutations in the WFS1 gene. The exons 2–8 of the WFS1 gene from one Chinese WFS patient were amplified by the polymerase chain reaction (PCR), subcloning techniques and direct sequence determination was applied to the amplified fragments. The compound heterozygous mutation of a 3-bp (GAC) deletion (V434del) and another compound heterozygous mutation (G→N)(W666X) in exon 8 of WFS1 gene was identified in the patient. Other seventeen members of her family were investigated. Four cases with heterozygotes had been found through screening for the mutation V434del and five cases for the mutation W666X in the whole family. This is the first report of WFS with the mutation V434del and W666X in the WFS1 gene.
Literature
1.
go back to reference D.J. Wolfram, H.P. Wagener, Diabetes mellitus and simple optic atrophy among siblings: report of four cases. Mayo Clin. Proc. 9, 715–718 (1938) D.J. Wolfram, H.P. Wagener, Diabetes mellitus and simple optic atrophy among siblings: report of four cases. Mayo Clin. Proc. 9, 715–718 (1938)
2.
go back to reference N.J. Scolding, H.F. Kellar-Wood, C. Shaw et al., Wolfram syndrome: hereditary diabetes mellitus with brainstem and optic atrophy. Ann. Neurol. 39, 352–360 (1996)CrossRefPubMed N.J. Scolding, H.F. Kellar-Wood, C. Shaw et al., Wolfram syndrome: hereditary diabetes mellitus with brainstem and optic atrophy. Ann. Neurol. 39, 352–360 (1996)CrossRefPubMed
3.
go back to reference R.G. Swift, D.B. Sadler, M. Swift, Psychiatric findings in Wolfram syndrome homozygotes. Lancet 336, 667–669 (1990)CrossRefPubMed R.G. Swift, D.B. Sadler, M. Swift, Psychiatric findings in Wolfram syndrome homozygotes. Lancet 336, 667–669 (1990)CrossRefPubMed
4.
go back to reference E. Simsek, T. Simsek, S. Tekgül et al., Wolfram (DIDMOAD) syndrome: a multidisciplinary clinical study in nine Turkish patients and review of literature. Acta Pediatr. 92, 55–61 (2003)CrossRef E. Simsek, T. Simsek, S. Tekgül et al., Wolfram (DIDMOAD) syndrome: a multidisciplinary clinical study in nine Turkish patients and review of literature. Acta Pediatr. 92, 55–61 (2003)CrossRef
5.
go back to reference T.G. Barrett, S.E. Bundey, A.F. Macleod, Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 345, 1458–1463 (1995)CrossRef T.G. Barrett, S.E. Bundey, A.F. Macleod, Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 345, 1458–1463 (1995)CrossRef
6.
go back to reference B.T. Kinsley, M. Swift, R.H. Dumont et al., Morbidity and mortality in the Wolfram syndrome. Diabetes Care 18, 1566–1570 (1995)CrossRefPubMed B.T. Kinsley, M. Swift, R.H. Dumont et al., Morbidity and mortality in the Wolfram syndrome. Diabetes Care 18, 1566–1570 (1995)CrossRefPubMed
7.
go back to reference H. Inoue, Y. Tanizawa, J. Wasson et al., A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat. Genet. 20, 143–148 (1998)CrossRefPubMed H. Inoue, Y. Tanizawa, J. Wasson et al., A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat. Genet. 20, 143–148 (1998)CrossRefPubMed
8.
go back to reference T.M. Strom, K. Hortnagel, S. Hofmann et al., Diabetes insipidus, diabetes mellitus, optic atrophy, deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum. Mol. Genet. 7, 2021–2028 (1998)CrossRefPubMed T.M. Strom, K. Hortnagel, S. Hofmann et al., Diabetes insipidus, diabetes mellitus, optic atrophy, deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum. Mol. Genet. 7, 2021–2028 (1998)CrossRefPubMed
9.
go back to reference C. Hardy, F. Khanim, R. Torres et al., Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1. Am. J. Hum. Genet. 65, 1279–1290 (1999)CrossRefPubMed C. Hardy, F. Khanim, R. Torres et al., Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1. Am. J. Hum. Genet. 65, 1279–1290 (1999)CrossRefPubMed
10.
go back to reference A. Rotig, V. Cormier, P. Chatelain et al., Deletion of mitochondrial DNA in a case of early-onset diabetes mellitus, optic atrophy and deafness (DIDMOAD, Wolfram syndrome). J. Inherit. Metab. Dis. 16, 527–530 (1993)CrossRefPubMed A. Rotig, V. Cormier, P. Chatelain et al., Deletion of mitochondrial DNA in a case of early-onset diabetes mellitus, optic atrophy and deafness (DIDMOAD, Wolfram syndrome). J. Inherit. Metab. Dis. 16, 527–530 (1993)CrossRefPubMed
11.
go back to reference S. Bundey, K. Poulton, H. Whitwell et al., Mitochondrial abnormalities in the DIDMOAD syndrome. J. Inherit. Metab. Dis. 15, 315–319 (1992)CrossRefPubMed S. Bundey, K. Poulton, H. Whitwell et al., Mitochondrial abnormalities in the DIDMOAD syndrome. J. Inherit. Metab. Dis. 15, 315–319 (1992)CrossRefPubMed
12.
go back to reference A. Barrientos, J. Casademont, A. Saiz et al., Autosomal recessive Wolfram syndrome associated with an 8.5-kb mtDNA single deletion. Am. J. Hum. Genet. 58, 963–970 (1996)PubMed A. Barrientos, J. Casademont, A. Saiz et al., Autosomal recessive Wolfram syndrome associated with an 8.5-kb mtDNA single deletion. Am. J. Hum. Genet. 58, 963–970 (1996)PubMed
13.
go back to reference M.J. Jackson, V.L.A. Bindo, K. Weber et al., Biochemical and molecular studies of mitochondrial function in diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. Diabetes Care 17, 728–733 (1994)CrossRefPubMed M.J. Jackson, V.L.A. Bindo, K. Weber et al., Biochemical and molecular studies of mitochondrial function in diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. Diabetes Care 17, 728–733 (1994)CrossRefPubMed
14.
go back to reference V. Seyrantepe, H. Topaloglu, E. Simsek et al., Mitochondrial DNA studies in Wolfram (DIDMOAD) syndrome. Lancet 347, 695–696 (1996)CrossRefPubMed V. Seyrantepe, H. Topaloglu, E. Simsek et al., Mitochondrial DNA studies in Wolfram (DIDMOAD) syndrome. Lancet 347, 695–696 (1996)CrossRefPubMed
15.
go back to reference S. Hofmann, R. Bezold, M. Jaksch et al., Wolfram (DIDMOAD) syndrome and Leber hereditary optic neuropathy (LHON) are associated with distinct mitochondrial DNA haplotypes. Genomics 39, 8–18 (1997)CrossRefPubMed S. Hofmann, R. Bezold, M. Jaksch et al., Wolfram (DIDMOAD) syndrome and Leber hereditary optic neuropathy (LHON) are associated with distinct mitochondrial DNA haplotypes. Genomics 39, 8–18 (1997)CrossRefPubMed
16.
go back to reference T.G. Barrett, M. Scott-Brown, A. Seller et al., The mitochondrial genome in Wolfram syndrome. J. Med. Genet. 37, 463–466 (2000)CrossRefPubMed T.G. Barrett, M. Scott-Brown, A. Seller et al., The mitochondrial genome in Wolfram syndrome. J. Med. Genet. 37, 463–466 (2000)CrossRefPubMed
17.
go back to reference H. El-Shanti, A.C. Lidral, N. Jarrah et al., Homozygosity mapping identifies an additional locus for Wolfram syndrome on chromosome 4q. Am. J. Hum. Genet. 66, 1229–1236 (2000)CrossRefPubMed H. El-Shanti, A.C. Lidral, N. Jarrah et al., Homozygosity mapping identifies an additional locus for Wolfram syndrome on chromosome 4q. Am. J. Hum. Genet. 66, 1229–1236 (2000)CrossRefPubMed
18.
go back to reference A. Barrientos, V. Volpini, J. Casademont et al., Anuclear defect in the 4p16 region predisposes to multiple mitochondrial DNA deletions in families with Wolfram syndrome. J. Clin. Invest. 97, 1570–1576 (1996)CrossRefPubMed A. Barrientos, V. Volpini, J. Casademont et al., Anuclear defect in the 4p16 region predisposes to multiple mitochondrial DNA deletions in families with Wolfram syndrome. J. Clin. Invest. 97, 1570–1576 (1996)CrossRefPubMed
19.
go back to reference R.G. Swift, D.O. Pekins, C.L. Chase et al., Psychiatric disorders in 36 families with Wolfram syndrome. Am. J. Psychiatry 148, 775–779 (1991)PubMed R.G. Swift, D.O. Pekins, C.L. Chase et al., Psychiatric disorders in 36 families with Wolfram syndrome. Am. J. Psychiatry 148, 775–779 (1991)PubMed
20.
go back to reference P. Baz, S. Azar, R. Medlej et al., Role of early funduscopy for diagnosis of wolfram syndrome in type I diabetic patients. Diabetes Care 22, 1376–1377 (1999)CrossRefPubMed P. Baz, S. Azar, R. Medlej et al., Role of early funduscopy for diagnosis of wolfram syndrome in type I diabetic patients. Diabetes Care 22, 1376–1377 (1999)CrossRefPubMed
21.
go back to reference C. Leiva-Santana, A. Carro-Martinez, A. Monge-Argiles et al., Neurologic manifestations in Wolfram syndrome. Rev. Neurol. 149, 26–29 (1993)PubMed C. Leiva-Santana, A. Carro-Martinez, A. Monge-Argiles et al., Neurologic manifestations in Wolfram syndrome. Rev. Neurol. 149, 26–29 (1993)PubMed
22.
go back to reference D. Genis, A. Davalos, A. Molins et al., Wolfram syndrome: a neuropathological study. Acta Neuropathol. 93, 426–429 (1997)CrossRefPubMed D. Genis, A. Davalos, A. Molins et al., Wolfram syndrome: a neuropathological study. Acta Neuropathol. 93, 426–429 (1997)CrossRefPubMed
23.
go back to reference H.B. Grosse Aldenhovel, U. Gallenkamp, C.A. Sulemana, Juvenile onset diabetes mellitus, central diabetes insipidus and optic atrophy (Wolfram syndrome)—neurological findings and prognostic implications. Neuropediatrics 22, 103–106 (1991)CrossRefPubMed H.B. Grosse Aldenhovel, U. Gallenkamp, C.A. Sulemana, Juvenile onset diabetes mellitus, central diabetes insipidus and optic atrophy (Wolfram syndrome)—neurological findings and prognostic implications. Neuropediatrics 22, 103–106 (1991)CrossRefPubMed
24.
go back to reference A.T. Soliman, B. Bappal, A. Darwish et al., Growth hormone deficiency and empty sella in DIDMOAD syndrome: an endocrine study. Arch. Dis. Child. 73, 251–253 (1995)CrossRefPubMed A.T. Soliman, B. Bappal, A. Darwish et al., Growth hormone deficiency and empty sella in DIDMOAD syndrome: an endocrine study. Arch. Dis. Child. 73, 251–253 (1995)CrossRefPubMed
25.
go back to reference K. Takeda, H. Inoue, Y. Tanizawa et al., WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain. Hum. Mol. Genet. 10, 477–484 (2001)CrossRefPubMed K. Takeda, H. Inoue, Y. Tanizawa et al., WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain. Hum. Mol. Genet. 10, 477–484 (2001)CrossRefPubMed
26.
go back to reference M. Al-Sheyyab, N. Jarrah, E. Younis et al., Bleeding tendency in Wolfram syndrome: a newly identified feature with phenotype-genotype correlation. Eur. J. Pediatr. 160, 243–246 (2001)CrossRefPubMed M. Al-Sheyyab, N. Jarrah, E. Younis et al., Bleeding tendency in Wolfram syndrome: a newly identified feature with phenotype-genotype correlation. Eur. J. Pediatr. 160, 243–246 (2001)CrossRefPubMed
27.
go back to reference Y. Tanizawa, H. Inoue, Y. Oka, Positional cloning of the gene (WFS1) for Wolfram syndrome. Rinsho Byori 48, 941–947 (2000)PubMed Y. Tanizawa, H. Inoue, Y. Oka, Positional cloning of the gene (WFS1) for Wolfram syndrome. Rinsho Byori 48, 941–947 (2000)PubMed
28.
go back to reference M.H. Polymeropoulos, R.G. Swift, M. Swift, Linkage of the gene for Wolfram syndrome to markers on the short arm of chromosome 4. Nat. Genet. 8, 95–97 (1994)CrossRefPubMed M.H. Polymeropoulos, R.G. Swift, M. Swift, Linkage of the gene for Wolfram syndrome to markers on the short arm of chromosome 4. Nat. Genet. 8, 95–97 (1994)CrossRefPubMed
29.
go back to reference D.A. Collier, T.G. Barrett, D. Curtis et al., Linkage of Wolfram syndrome to chromosome 4p16.1 and evidence for heterogeneity. Am. J. Hum. Genet. 59, 855–863 (1996)PubMed D.A. Collier, T.G. Barrett, D. Curtis et al., Linkage of Wolfram syndrome to chromosome 4p16.1 and evidence for heterogeneity. Am. J. Hum. Genet. 59, 855–863 (1996)PubMed
30.
go back to reference A. Tessa, I. Carbone, M.C. Matteoli et al., Identification of novel WFS1 mutations in Italian children with Wolfram syndrome. Hum. Mutat. 17, 348–349 (2001)CrossRefPubMed A. Tessa, I. Carbone, M.C. Matteoli et al., Identification of novel WFS1 mutations in Italian children with Wolfram syndrome. Hum. Mutat. 17, 348–349 (2001)CrossRefPubMed
31.
go back to reference M. Gomez-Zaera, T.M. Strom, B. Rodriguez et al., Presence of a major WFS1 mutation in Spanish Wolfram syndrome pedigrees. Mol. Genet. Metab. 72, 72–81 (2001)CrossRefPubMed M. Gomez-Zaera, T.M. Strom, B. Rodriguez et al., Presence of a major WFS1 mutation in Spanish Wolfram syndrome pedigrees. Mol. Genet. Metab. 72, 72–81 (2001)CrossRefPubMed
32.
go back to reference S. Tekgul, O. Oge, E. Simsek et al., Urological manifestation of the Wolfram syndrome: observations in 14 patients. J. Urol. 161(2), 616–617 (1999)CrossRefPubMed S. Tekgul, O. Oge, E. Simsek et al., Urological manifestation of the Wolfram syndrome: observations in 14 patients. J. Urol. 161(2), 616–617 (1999)CrossRefPubMed
33.
go back to reference F.J. Anglada Curado, M. Leva Vallejo et al., Wolfram syndrome: urologic implications. Actas Urol. Esp. 24, 504–508 (2000)PubMed F.J. Anglada Curado, M. Leva Vallejo et al., Wolfram syndrome: urologic implications. Actas Urol. Esp. 24, 504–508 (2000)PubMed
Metadata
Title
The novel compound heterozygous mutations, V434del and W666X, in WFS1 gene causing the Wolfram syndrome in a Chinese family
Authors
Jie Hong
Yu-wen Zhang
Hui-Jie Zhang
Hui-ying Jia
Yu Zhang
Xiao-yi Ding
Dan-yang Zhou
Hui-ping Chen
Xiao-hua Jiang
Bin Cui
Xiao-ying Li
Guang Ning
Publication date
01-04-2009
Publisher
Springer US
Published in
Endocrine / Issue 2/2009
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-009-9145-7

Other articles of this Issue 2/2009

Endocrine 2/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine